They should begin growing and processing in 2018. The Pennsylvania Department of Health announced the first 12 recipients of coveted grower and Medical marijuana processor permits, and Lehigh Valley applicants were shut out. Regionally, two Berks County businesses won licenses as did a company in Luzerne County and one in Lackawanna County. They should begin growing and processing in 2018. Pollack said he hasn’t heard any reports of doctors being prosecuted or cut off by insurance companies or asked to leave their practices because they recommended marijuana for patients. “I think it would create so much adverse publicity for the hospitals and insurance companies, it probably wouldn’t happen,” he said. In Pennsylvania, 17 conditions qualify for treatment with medical marijuana, including several not covered in New Jersey: autism, damage to nervous tissue and intractable pain. Patients won’t be able to smoke the drug, which will only be available in the form of pills, oils, topical gels, creams or ointments. The plant’s active ingredient could also be prescribed in liquid form to be used with a vaporizer or nebulizer. “Pennsylvania’s program is so much broader than New Jersey or New York’s,” said Becky Dansky, legislative counsel for the Marijuana Policy Project, which supports medical marijuana use and reducing penalties for recreational use.
To read more visit http://www.mcall.com/news/nationworld/pennsylvania/mc-nws-medical-marijuana-doctor-participation-20170627-story.html
In a time when competition is growing, this is an advantage. “Dispensaries can use employees during downtime and maximize employee output. They’re giving patients an experience that competitors are not,” Schudel said. Level-Up dispensary in Scottsdale has been on board for a few weeks but has already seen an increase in new clientele who found it via Supurb, said Jenna Urusky, marketing director at Level-Up. “One of Supurb’s strengths is that people can find us organically and they are finding us now,” she said. Previously, Level-Up had an arrangement where customers could pick up their orders at a central location. But after using Suburb, they have eliminated that option. Urusky said the speed and ease of getting Level-Up up and running and Supurb’s hands-on training underscored it was the right choice. “People really like the convenience.
To read more visit http://www.azcentral.com/story/news/local/tempe/2017/07/11/supurb-delivers-medical-marijuana-from-arizona-dispensaries/364069001/
For those who may not recall, the DEA had an opportunity to review medical cannabis last year as part of two petitions that requested it be removed as a Schedule 1 drug. Schedule 1 drugs, like LSD and heroin, are defined as having no medical benefits and are entirely illegal. After review, the DEA declined to reschedule marijuana, with the regulatory agency citing a lack of clinical benefit and risk data in its decision. The DEA also noted that a lack of marijuana use oversight steered it away from rescheduling the Marijuana Stocks drug. This brings up one of the great Catch-22s of medical marijuana: The DEA wants more clinical data from Food and Drug Administration-approved trials, but researchers can’t get these studies off the ground because its Schedule 1 status is so restrictive. The federal government is also unlikely to make things easier for drug developers. Even though President Trump threw his support behind medical marijuana during his campaign, his newly appointed attorney general, Jeff Sessions, is possibly the biggest opponent on Capitol Hill of its expansion (medically or recreationally). As long as Sessions sits on Trump’s cabinet, any easing of federal restrictions seems very unlikely. So, what does this mean for marijuana stocks and patients?
To read more visit https://www.fool.com/investing/2017/07/08/wow-92-of-patients-prefer-medical-marijuana-to-opi.aspx
A Tampa-based attorney is now leading that still-longshot effort. Frank Gluck/The News-Press 986 CONNECT TWEET 9 LINKEDIN 21 COMMENTEMAILMORE More than 71 percent of Florida voters in November agreed marijuana should be used to treat serious illnesses – the highest margin of support among the nine states considering various levels of cannabis legalization last year. Given that kind of public backing, a group trying to legalize adult recreational cultivation and consumption of the drug hopes 2018 will finally be the year Green Rush cannabis prohibition fully ends in the Sunshine State. The organization, Regulate Florida , is making its second — though still under-the-radar — attempt to get its proposed constitutional amendment on the state ballot. “We have the wind in our sails and the tide of the country on our side. The polls for legalization continue to climb,” said Tampa attorney Michael Minardi, who is leading the legalization effort. “The attitudes and the perceptions and acceptance of this issue has changed dramatically, even since the election of 2016.” But if funding, staffing and the lack of deep-pocketed backers are any guides, pro-marijuana Floridians probably shouldn’t count on an easy win anytime soon. The group, which claims dozens of volunteers, must collect more than 750,000 valid signatures by early next year to get the measure on the ballot. To date, it’s collected about 20,000, Minardi said. Minardi’s political action committee, Sensible Florida Inc., has received about $245,000 in donations and in-kind services since 2015, nearly a quarter of which came from Minardi himself.
To read more visit http://www.news-press.com/story/news/2017/07/07/medical-marijuana-now-legal-florida-recreational-pot-far-behind/452965001/
Sessions’s Backdoor Attempt to Outlaw Medical Marijuana This article first appeared on Reason.com. In a previously undisclosed letter sent last month, Attorney General Jeff Sessions asked lawmakers not to renew a rider that blocks the Justice Department from interfering with the implementation of state-level medical marijuana laws. “I believe it would be unwise for Congress to restrict the discretion of the Department to fund particular prosecutions,” Sessions wrote, “particularly in the midst of an historic drug epidemic and potentially long-term uptick in violent crime. The Department must be in a position to use all laws available to combat the transnational drug organizations and dangerous drug traffickers who threaten American lives.” Daily Emails and Alerts- Get the best of Newsweek delivered to your inbox The letter—dated May 1, 2017, and addressed to Sens. Mitch McConnell and Charles Medical marijuana stocks Schumer and Reps. Paul Ryan and Nancy Pelosi— was obtained by Massroots.com’s Tom Angell. It specifically asks that Congress not renew the Rohrabacher-Farr amendment , passed in 2014. Barack Obama’s Justice Department challenged the amendment last year, and it lost in the 9th Circuit Court of Appeals . That means if Sessions wants to go after medical marijuana, he’ll need Congress to remove Rohrabacher-Farr from the next appropriations bill.
To read more visit http://www.newsweek.com/sessionss-backdoor-attempt-outlaw-medical-marijuana-628556
Trudeau’s primary focus isn’t on revenue generation for Canada, so much as weeding out (pun intended) the black market in his country. Price is easily the biggest differentiating factor between legal weed and under-the-table cannabis. People who operate in the black market don’t have to worry about paying taxes on the sale of their products, nor do they typically have marketing costs, or traditional brick-and-mortar expenses from having a physical store location. Legitimate businesses do have to contend with these fees and taxes, making it difficult to contend with under-the-table pricing. By settling on a very low sales tax rate, Trudeau believes he’ll be giving producers and retailers a reasonable chance of quickly squashing black-market sales by being price-competitive. Low taxes are a key to success for legal pot sales, but it’s also why an identical plan simply wouldn’t work in the United States. In the U.S., state governments are very much influenced by the sales tax and licensing revenue generated by legal weed sales when passing legislation. Given how many budget holes there are among the 50 U.S. states, convincing states to lower taxes would be next to impossible. Take Colorado, as a good example.
To read more visit http://host.madison.com/business/investment/markets-and-stocks/canada-s-recreational-marijuana-approach-is-pure-genius-but-it/article_2e6d0127-3ca1-58e3-9741-f6b6cf8ad93d.html
The most prominent anti-marijuana group in the country is touting the absence of language in a key Congressional funding bill that has protected the medical marijuana industry in Colorado and beyond from federal prosecution in recent years. But a cannabis advocate dismisses the suggestion that this development could soon unleash a law-enforcement blitzkrieg against the MMJ biz. In the words of Tom Angell, who leads the national organization Marijuana Majority, “This is a gigantic nothingburger.” That’s not the way it’s being portrayed by Smart Approaches to Marijuana , also known as Project SAM, which launched in Colorado in 2013 . In its first press release on the topic, the organization maintains that a “Commerce, Justice, Science bill that funds the Department of Justice…eliminated a provision that has protected the marijuana industry from federal prosecution for violating the Controlled Substances Act.” Anti-Pot Group Project SAM Claims Teen Pot Use Is Soaring, Then Admits It’s Not This line refers to language created by representatives Dana Rohrabacher and Sam Farr, a pair of California Republicans, that bars the Department of Justice from prosecuting anyone following the laws in states that allow medical marijuana. In an April letter to the subcommittee handling the bill (it’s accessible below), Rohrabacher and more than thirty fellow members of Congress, including Colorado reps Jared Polis, Ed Perlmutter and Diana DeGette, asked that the language be included in the measure, and SAM says it did appear for a time in the base text. But it’s absent from the version released yesterday, June 28. Courtesy of Smart Approaches to Marijuana SAM submitted testimony to the Appropriations Committee arguing against the language, and now that it’s out, Kevin Sabet, the group’s president, is celebrating in a big way. In one quote sprinkled with dubious assertions, he says, “If I were an investor, I would sell my marijuana stocks short. The marijuana industry has lost in every state in which they were pushing legislation in 2017, the industry’s largest lobbying group is losing its bank account, and now they are losing protection that has helped them thrive despite marijuana’s illegal status.
To read more visit http://www.westword.com/news/anti-marijuana-group-celebrates-threat-to-medical-marijuana-industry-9210752
The House bill was shelved on Feb. 27 in the rules committee where it remained stuck. A Senate companion bill later met the same fate. Sen. Terry Van Duyn was a companion bill sponsor. Chuck Edwards, a Hendersonville Republican whose senate district covers part of South Asheville and Buncombe, was not. “Committees have shut down on the Senate side, which means no new bills will be coming to the floor,” Van Duyn said Thursday. “There are exceptions, of course, for stuff they want to slip by us, but nothing progressive would fall into that category.” House Rules Committee Chairman Rep. David Lewis of Harnett County did not return an email and phone call Friday seeking comment. Commenting on a similar bill in 2016 Lewis didn’t rule out Republican backing for the legislation. “I think there are many members of the House that are keenly aware of the challenges that terminally ill patients face and the dangers of many of the synthetic drugs that are out there,” Lewis told the Carolina Journal.
To read more visit http://www.citizen-times.com/story/news/local/2017/06/30/gop-blocks-medical-pot-backed-asheville-council-regions-hospital-ceo/442676001/
Uh-Oh! Canada’s Recreational Marijuana Bill Could Be in Serious Trouble (Along With Canadian Pot Stocks) The marijuana industry has been practically unstoppable over the past couple of years, which is a big reason why investors have flocked to marijuana stocks, and select state legislatures have moved to legalize cannabis as a means of generating new tax revenue. In North America, $6.9 billion worth of medical and recreational weed was sold last year, according to ArcView Market Research, though $46.4 billion in sales remained in black market channels. By 2021, ArcView foresees legal sales jumping to north of $22 billion annually, implying the ongoing legalization of pot in various U.S. states, and Marijuana Stocks perhaps north and south of the U.S. border. The potential to move current black market consumers into legal channels is the entire reason why marijuana stocks have been soaring of late. However, between medical cannabis and recreational weed, the Holy Grail for the industry would be a countrywide recreational approval. The market for adult-use pot is substantially larger than medical cannabis, but just one country worldwide, Uruguay, has legalized the sale of recreational marijuana. Currently, our neighbors to the north, Canada, aim to become the second. A recently introduced bill by Prime Minister Justin Trudeau, a longtime supporter of a countrywide recreational marijuana legalization effort, is targeting July 1, 2018 as the date where recreational pot would become legal in Canada. Per various sources, the bill would allow adults ages 21 and up to buy recreational weed, possess up to 30 grams, which is a little over an ounce, and grow up to four plants in their household at a time.
To read more visit http://host.madison.com/business/investment/markets-and-stocks/uh-oh-canada-s-recreational-marijuana-bill-could-be-in/article_4fab242e-0f09-59b2-b8d6-53e37254202c.html
(D-At Large), who sponsored the legislation that passed Tuesday. “We have locked up so many black people for marijuana, and I see it as incredibly hypocritical for those folks to return from prison on marijuana charges just to come back to a place that has now legalized and industrialized it, and they can’t play any role.” [ Battling racial roadblocks to join marijuana industry ] The emergency bill to give minority-owned businesses extra weight on their applications comes as the District is preparing to award a permit to open a dispensary in the overwhelmingly black neighborhoods east of the Anacostia River. A spokeswoman for Mayor Marijuana Stocks Muriel E. Bowser (D) says she’s still reviewing the legislation, but her administration is taking steps to implement it. The Health Department will allow companies that submitted letters of intent to seek a dispensary license to qualify as a minority-owned business, spokeswoman Jasmine Gossett said. She had no timeline for when the agency would issue new licenses, as regulations allowing new dispensaries are still being written. In February, the District lifted its prohibition against felons convicted of possession with the intent to distribute marijuana from entering the medical marijuana industry, citing racial disparities in how the law was enforced. The District currently has eight cultivation centers and five dispensaries. Only one cultivator is black.
To read more visit https://www.washingtonpost.com/local/dc-politics/dc-poised-to-give-minorities-preference-for-entering-medical-marijuana-industry/2017/06/30/aae20b68-5d09-11e7-9b7d-14576dc0f39d_story.html